Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
7.10
-0.01 (-0.14%)
At close: Apr 17, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.72 billion as of April 17, 2026. Its market cap has increased by 1.56% in one year.
Market Cap
1.72B
Enterprise Value
1.10B
Revenue
1.45B
Ranking
n/a
PE Ratio
11.33
Stock Price
7.10
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.72B, a decrease of -8.53%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 1.72B | -7.44% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.29B |
| Immunotech Biopharm | 2.22B |
| Frontage Holdings | 2.05B |
| HighTide Therapeutics | 1.99B |
| Mabpharm | 1.98B |
| Cutia Therapeutics | 1.68B |
| Zhaoke Ophthalmology | 1.66B |
| CANbridge Pharmaceuticals | 1.57B |